{"id":255,"date":"2014-08-17T12:36:04","date_gmt":"2014-08-17T11:36:04","guid":{"rendered":"http:\/\/www.waynemedicineandpoetry.co.uk\/?p=255"},"modified":"2023-12-08T00:56:26","modified_gmt":"2023-12-08T00:56:26","slug":"publications","status":"publish","type":"post","link":"http:\/\/www.waynemedicineandpoetry.co.uk\/?p=255","title":{"rendered":"Publications"},"content":{"rendered":"
    \n
  1. Human Fascioliasis in Rhodesia. Journal of Tropical Medicine and Hygiene 1972; 75:\u00a0221-223. Perry W, Goldsmith JM and Gelfand M.<\/li>\n
  2. Emetine and Cyclophosphamide in Carcinoma of the Lung. Lancet 1972; 2: 427. Hyde KR, Marsh K, Perry W. (Letter).<\/li>\n
  3. Peritoneal Tuberculosis Presenting as Pyrexia of Unknown Origin in Immigrants.\u00a0\u00a0\u00a0\u00a0 Journal of Tropical Medicine and Hygiene 1976; 79: 83-88. Perry W and McKerron CG.<\/li>\n
  4. Vitamin D Resistance in Osteomalacia FollowingUretero-Sigmoidostomy. New England\u00a0Journal of Medicine 1977; 279: 1110-1112. Perry W, Allen LN, Stamp TCB and Walker PG.<\/li>\n
  5. Hereditary Hypophosphataemic Rickets with Autosomal Recessive Inheritance and\u00a0Severe Osteosclerosis. Journal of Bone and Joint Surgery 1978; 60: 430-434. Perry W\u00a0and Stamp TCB.<\/li>\n
  6. Metabolic Effects of Enzyme Induction and Inhibition by Rifampicin and Isoniazid.\u00a0Essay awarded the Seddon Gold Medal and Prize, Royal National Orthopaedic Hospital\u00a0and Institute of Orthopaedics University of London 1978. Perry W. See refs 7, 15, 21, 24, 25, 26, 27)<\/li>\n
  7. Elevation of Plasma Levels of Lysosomal Enzymes during Treatment with Rifampicin\u00a0and Isoniazid. Biochemical Medicine 1978; 20: 153-159. Perry W, Jenkins MV, Stamp\u00a0TCB.<\/li>\n
  8. Induction and Inhibition of Hepatic Microsomal Enzymes by Rifampicin and Isoniazid.\u00a0Clinical Science and Molecular Medicine 1978; 55: 1-2P. Perry W, Jenkins MV, Erooga\u00a0MA, Setchell KDR and Stamp TCB.<\/li>\n
  9. Treatment of Privational Late Rickets and Osteomalacia with the Vitamins D. In\u00a0Vitamin D Basic Research and its Clinical. Application Walter de Gryer and Company,\u00a0Berlin, New York 1979; 1153-1162. Stamp TCB, Perry W, MacArthur S and Jenkins\u00a0MV.<\/li>\n
  10. Treatment of Bone and Joint Tuberculosis. In Rifampicin in Extra-Pulmonary\u00a0Tuberculosis Royal Society of Medicine International Congress and Symposium No. 11.\u00a0Academic Press Inc (London) and the Royal Society of Medicine 1979; 19-27. Perry W.<\/li>\n
  11. Lysosomal Enzymes and Pancreatitis During Rifampicin Therapy. Lancet 1979; 1: 492.\u00a0Perry W, Jenkins MV and Stamp TCB (Letter).<\/li>\n
  12. Treatment of Hypophosphataemic Tumour Osteomalacia and of Hyperphosphataemic\u00a0Tumoural Calcinosis. 4th International Workshop on Phosphate and Other Minerals,\u00a0Strasburg, France, 1979. Stamp TCB, Perry W, Jenkins MV and Parsons JA.<\/li>\n
  13. Male Infertility. Al-Faisal Medical Journal No. 2, November 1980; 8-11. (Published at\u00a0King Faisal University, Dammam, Saudi Arabia). Perry W.<\/li>\n
  14. Nutritional Osteomalacia and Late Rickets in Greater London 1974-1979: Clinical and\u00a0Metabolic Studies in 45 Patients. Clinics in Endocrinology and Metabolism 1980; Vol. 9:\u00a0No. 1, 81-105. Stamp TCB, Walker PG, Perry W and Jenkins MV.<\/li>\n
  15. Isoniazid Inhibition of Rifampicin-Mediated Enzyme Induction. Saudi Medical Journal\u00a01981; 2: 67-71. Perry W.<\/li>\n
  16. Value of Serum Gonadotrophin and Testicular Biopsy in the Aetiology of Azoospermia:\u00a0Report of Three Illustrative Cases and Review of the Problem. 6th Saudi Medical\u00a0Conference Jeddah, Saudi Arabia, 1981. Perry W, Kubba A and Lautsch EV.<\/li>\n
  17. Clinico-Pathological Appraisal of Male Infertility in Saudi Arabia. 6th Saudi Medical\u00a0Conference, Jeddah., Saudi Arabia, 1981. Kubba A, Lautsch EV and Perry W. (Not included).<\/li>\n
  18. Calcium Metabolism During Rifampicin and Isoniazid Therapy for Tuberculosis. Journal\u00a0of the Royal Society of Medicine 1982; 75: 533-536. Perry W, Erooga MA, Brown J and\u00a0Stamp TCB.<\/li>\n
  19. Metabolic Consequences of Rifampicin-Mediated Enzyme Induction during treatment for\u00a0Tuberculosis. Current Chemotherapy and Immunotherapy Proc 12th International\u00a0Congress of Chemotherapy 1982. Vol. 2, 987-990. Perry W, Jenkins MW, Brown J,\u00a0Erooga MA, Setchell KDR and Stamp TCB.<\/li>\n
  20. Endocrine Assessment of the Subfertile Male in Saudi Arabia. 7th Saudi Medical Conference, King Faisal University, Dammam, Saudi Arabia 1983; 145-149. Perry W.<\/li>\n
  21. Calcium Metabolism During Rifampicin and Isoniazid Therapy. Tubercle 1983;64: 57-\u00a058. Perry W. (Letter).<\/li>\n
  22. Calcium Metabolism During Rifampicin and Isoniazid Therapy. Journal of the Royal Society of Medicine 1983; 76: 326-327. Perry W. (Letter).<\/li>\n
  23. Case of Situs Inversus and Embryonic Ovarian Carcinoma. Gynaecologic Oncology\u00a01984; 18: 270-273. Ibrahim EM, Al Farag A, Al Tamimi D and Perry W.<\/li>\n
  24. Studies of Urinary D-Glucaric Acid Excretion During Rifampicin Isoniazid and\u00a0Anticonvulsant Enzyme Induction. Clinical Pharmacology and Therapeutics 1984; 35:\u00a0710-715. Perry W and Stamp TCB.<\/li>\n
  25. Hepatic Mixed Function Oxidase Activity During Rifampicinilsoniazid Therapy in Indian\u00a0Vegetarians. International Journal of Clinical Pharmacology, Therapeutics and\u00a0Toxicology 1986; 24: 344-348. Perry W and Jenkins MV.<\/li>\n
  26. Note on the Enzyme Assay for Urinary D-Glucaric Acid and Correlation with Rifampicin\u00a0Induced Mixed Function Oxidase Activity. International Journal of Clinical\u00a0Pharmacology, Therapeutics and Toxicology 1986; 24: 609-613. Perry W and Jenkins MV.<\/li>\n
  27. Plasma Gamma Glutamyltranspeptidase during Rifampicin Treatment for Tuberculosis.\u00a0International Journal of Clinical Pharmacology, Therapeutics and Toxicology, 1987; 25:\u00a07-9. Perry W and Jenkins MV.<\/li>\n
  28. Rifampicin, Glucose and Halothane as Mediators of Lysosomal Enzyme Induction.\u00a0Medical Hypotheses, 1988; 26: 131-134. Perry W.<\/li>\n
  29. Value of EDTA in Atherosclerosis. The Royal College of General Practitioners 1988;\u00a0Members Book 213-214. Perry W.<\/li>\n
  30. Osteoporosis: Prevention, Detection, Treatment. EDC: Update Series 1989. Mortimer\u00a0CH and Perry W. (Personal publication).<\/li>\n
  31. Skeletal Effects of Oestrogen and Testosterone in Postmenopausal Women. British\u00a0Medical Journal 1988; 297: 6870688. Mortimer CH and Perry W. (Letter).<\/li>\n
  32. EDC Newsletter: March 1989. sHRT and osteopenia overdosing on oestrogen?\u00a0Mortimer CH and Perry W. (Personal publication).<\/li>\n
  33. EDC Newsletter: June 1989. Osteoporosis Screening: An Essential Part of\u00a0Gynaecological Assessment. Mortimer CH and Perry W. (Personal publication).<\/li>\n
  34. EDC Newsletter: November 1989. Osteoporosis Evaluation: Secondary Causes\u00a0Common. Mortimer CH and Perry W. (Personal publication).<\/li>\n
  35. Bone Density Screening for Osteoporosis. Lancet 1990; 336: 502-503. Andersson MI,\u00a0Mortimer CH and Perry W. (Letter).<\/li>\n
  36. Bone Density Screening for Osteoporosis. Lancet 1990; 336:1133-1134. Andersson Ml,\u00a0Mortimer CH and Perry W. (Letter).<\/li>\n
  37. Effect of Methylcysteine on Lipoprotein ‘a’ Levels. Pilot Study. Report submitted to\u00a0Sinclair Pharmaceuticals, Godalming, Surrey. October 1992.<\/li>\n
  38. Osteoporosis Screening in a Largely Self-Referred Population: High Prevalence But Low\u00a0Medical Priority. Why? Mineral and Electrolyte Metabolism 1994; 20: 287-293. Perry\u00a0W, Andersson MI and Mortimer CH.<\/li>\n
  39. Primary Hyperparathyroidism and Vitamin D Deficiency. Clinical Endocrinology 1995;\u00a043: 130. Perry W. (Letter).<\/li>\n
  40. Measurement of Bone Density in Osteoporosis. British Medical Journal 1995; 311: 952.\u00a0Perry W. (Letter).<\/li>\n
  41. Ability of bone mineral density to predict osteoporotic fractures: Case for screening\u00a0exists. British Medical Journal 1996; 313: 561. Perry W. (Letter).<\/li>\n
  42. Bone mineral density measurement. Journal of Royal Society of Medicine. 1996; 89:\u00a0599. Perry W. (Letter).<\/li>\n
  43. Osteoporosis management. Prescribers Journal. 1997; 37: No, 4: 250. Perry W. (Letter).<\/li>\n
  44. Combined oral oestradiol valerate-norethisterone treatment over three years in\u00a0postmenopsausal women. 1. Clinical aspects and endometrial histology. Gynaecological\u00a0Endocrinology. 1998; 12: 109-122. Perry W, Wiseman R, Cullen NM.<\/li>\n
  45. Combined oral oestradiol valerate-norethisterone treatment over three years in\u00a0postmenopausal women. Correlation between oestrogen levels and bone mineral density\u00a0sites. Perry W, Wiseman R.A. British Journal of Obstetrics and Gynaecology. 2000;\u00a0107: 1401-1406.<\/li>\n
  46. The effect on climacteric symptoms of oestrogen replacement therapy with a novel
    \noestradiol acetate intravaginal ring in post-menopausal women. Buckler H, Perry W.\u00a0British Menopause Society Meeting. June 28-29th 2001.<\/li>\n
  47. Comparison of a novel intravaginal ring delivering oestradiol valerate vs oral oestradiol for vasomotor symptom relief in postmenopausal women. Al-Azzawi F, Sarni S, Wahab\u00a0M, Perry W, Buckler H. British Menopause Society Meeting. June 28-29th 2001.<\/li>\n
  48. Combined oral oestradiol valerate-norethisterone treatment over three years in post-\u00a0menopausal women. Effect on lipids, coagulation factors, haematology and biochemistry.\u00a0Perry W, Wiseman RA. Maturitas 2002. 42: 157-164.<\/li>\n
  49. Cardiac cartography. Submitted to BMJ July 2004. (Under revision).<\/li>\n
  50. Clinical Trial Studies.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Human Fascioliasis in Rhodesia. Journal of Tropical Medicine and Hygiene 1972; 75:\u00a0221-223. Perry W, Goldsmith JM and Gelfand M. Emetine and Cyclophosphamide in Carcinoma of the Lung. Lancet 1972; 2: 427. Hyde KR, Marsh K, Perry W. (Letter). Peritoneal Tuberculosis Presenting as Pyrexia of Unknown Origin in Immigrants.\u00a0\u00a0\u00a0\u00a0 Journal of Tropical Medicine and Hygiene 1976; […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-255","post","type-post","status-publish","format-standard","hentry","category-medicine"],"_links":{"self":[{"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=255"}],"version-history":[{"count":3,"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/255\/revisions"}],"predecessor-version":[{"id":988,"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/255\/revisions\/988"}],"wp:attachment":[{"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=255"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.waynemedicineandpoetry.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}